
Gently clarifies pores

Soothes sensitive skin

No products in the cart.
$168.00
Now shipping: 99.55% purity | 12.16 mg
Cagrilintide, also known as AM833, is a peptide being developed by Novo Nordisk to help address obesity and type 2 diabetes. This peptide works by targeting amylin and calcitonin receptors to reduce appetite, and delay gastric emptying, and ultimately contributes to significant weight loss.
In some trials, it has been shown to stimulate greater weight loss when used in combination with another drug, semaglutide. This combo is marketed under the name CagrSema and is showing a lot of promise in treating conditions that are challenging to manage.
Please note that all products featured here are intended exclusively for research and development purposes. They are not designed for any form of human consumption. These products have not undergone evaluation by the U.S. Food and Drug Administration.
*Please note that all products featured here are intended exclusively for research and development purposes. They are not designed for any form of human consumption. These products have not undergone evaluation by the U.S. Food and Drug Administration.
â’¸ EliteEdge Biotech 2025. All rights reserved
Please note that all products featured on this website are intended exclusively for research and development purposes. They are not designed for any form of human consumption. The claims made on this website have not undergone evaluation by the U.S. Food and Drug Administration.
Neither the statements nor the products of this company aim to diagnose, treat, cure, or ward off any disease.
EliteEdge Biotech is a chemical supplier. EliteEdge Biotech is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic act. EliteEdge Biotech is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic act.
Reviews
There are no reviews yet.